Molecular basis of a yeast prion species barrier

Cell

Volumn 100, Issue 2, 2000, Pages 277-288

  Santoso, Alex ^a   Chien, Peter ^a,b   Osherovich, Lev Z ^a   Weissman, Jonathan S ^a  

^a Department of Pharmacology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL PROTEIN; PRION PROTEIN;

ARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN POLYMERIZATION; PROTEIN SYNTHESIS; YEAST;

MAMMALIA; MAMMALIAN PRIONS;

EID: 0034695569     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81565-2     Document Type: Article

References (37)

1. Agard, D.A., Hiraoka, Y., Shaw, P., and Sedat, J.W. (1989). Fluorescence microscopy in three dimensions. Methods Cell Biol. 30, 353-377.
2. Ausubel, F.M. (1987). Current Protocols in Molecular Biology (New York: Greene Pub. Associates and Wiley-Interscience).
3. Bailleul, P.A., Newnam, G.P., Steenbergen, J.N., and Chernoff, Y.O. (1999). Genetic study of interactions between the cytoskeletal assembly protein Sla1 and prion-forming domain of the release factor Sup35 (eRF3) in saccharomyces cerevisiae. Genetics 153, 81-94.
4. Bates, G.P., Mangiarini, L., Wanker, E.E., and Davies, S.W. (1998). Polyglutamine expansion and Huntington's disease. Biochem. Soc. Trans. 26, 471-475.
5. -like factors in the yeast saccharomyces cerevisiae. Curr. Genet. 24, 268-270.
6. Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge-Vechtomov, S.G., and Liebman, S.W. (1995). Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268, 880-884.
7. Come, J.H., Fraser, P.E., and Lansbury, P.T. (1993). A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc. Natl. Acad. Sci. USA 90, 5959-5963.
8. DePace, A.H., Santoso, A., Hillner, P., and Weissman, J.S. (1998). A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93, 1241-1252.
9. Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov, S.G., and Liebman, S.W. (1996). Genesis and variability of [PSI] prion factors in saccharomyces cerevisiae. Genetics 144, 1375-1386.
10. Doel, S.M., McCready, S.J., Nierras, C.R., and Cox, B.S. (1994). The dominant PNM2- mutation which eliminates the psi factor of saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. Genetics 137, 659-670.
11. Eaglestone, S.S., Cox, B.S., and Tuite, M.F. (1999). Translation termination efficiency can be regulated in saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J. 18, 1974-1981.
12. Edskes, H., Gray, V.T., and Wickner, R.B. (1999). The (URE3) prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl. Acad. Sci. USA 96, 1498-1503.
13. Frohman, M.A. (1993). Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE. Meth. Enzymol. 218, 340-356.
14. Glover, J.R., Kowal, A.S., Schirmer, E.C., Patino, M.M., Liu, J.J., and Lindquist, S. (1997). Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. Cerevisiae. Cell 89, 811-819.
15. Han, H., Weinreb, P.H., and Lansbury, P.T., Jr. (1995). The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2, 163-169.
16. Higgins, D.G., Thompson, J.D., and Gibson, T.J. (1996). Using clustal for multiple sequence alignments. Meth. Enzymol. 266, 383-402.
17. Horiuchi, M., and Caughey, B. (1999). Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J. 18, 3193-3203.
18. Ito, K., Ebihara, K., and Nakamura Y. (1998). The stretch of C-terminal acidic amino acids of translational release factor eRF1 is a primary binding site for eRF3 of fission yeast. RNA 4, 958-97
19. King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., and Wüthrich, K. (1997). Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. USA 94, 6618-6622.
20. Kocisko, D.A., Priola, S.A., Raymond, G.J., Chesebro, B., Lansbury, P.T., Jr., and Caughey, B. (1995). Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier. Proc. Natl. Acad. Sci. USA 92, 3923- 3927.
21. Koo, E.H., Lansbury, P.T., Jr., and Kelly, J.W. (1999). Amyloid diseases: Abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci USA 96, 9989-9990.
22. Kurtzman, C.P. (1994). Molecular taxonomy of the yeasts. Yeast 10, 1727-1740.
23. Kushnirov, V.V., Ter-Avanesyan, M.D., Didichenko, S.A., Smirnov, V.N., Chernoff, Y.O., Derkach, I.L., Novikova, O.N., Inge-Vechtomov, S.G., Neistat, M.A. and Tolstorukov, I.I. (1990). Divergence and conservation of SUP2 (SUP35) gene of yeast Pichia pinus and saccharomyces cerevisiae. Yeast 6, 461-472.
24. Lansbury, P.T., Jr. (1999). Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA 96, 3342-3344.
25. -chotic yeast: The expansion of the prion hypothesis. Cell 89, 495-498.
26. Liu, J.J., and Lindquist, S. (1999). Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast. Nature 400, 573-576.
27. Patino, M.M., Liu, J.J., Glover, J.R., and Lindquist, S. (1996). Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science 273, 622-626.
28. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. (1996). Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15, 3127-3134.
29. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. (1997). In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277, 381-383.
30. Prusiner, S.B., Scott, M.R., Dearmond, S.J., and Cohen, F.E. (1998). Prion protein biology. Cell 93, 337-348.
31. Sunde, M., and Blake, C. (1997). The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123-159.
32. Telling, G.C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F.E., Dearmond, S.J., and Prusiner, S.B. (1995). Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90.
33. Ter-Avanesyan, M.D., Kushnirov, V.V., Dagkesamanskaya, A.R., Didichenko, S.A., Chernoff, Y.O., Inge-Vechtomov, S.G., Smirnov, V.N. (1993). Deletion analysis of the SUP35 gene of the yeast saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol. Microbiol. 7, 683-692.
34. -] in saccharomyces cerevisiae. Genetics 98, 691-711.
35. Wickner, R.B. (1994). [URE3] as an altered URE2 protein: Evidence for a prion analog in saccharomyces cerevisiae. Science 264, 566-569.
36. Wickner, R.B., Masison, D.C., and Edskes, H.K. (1995). [PSI] and [URE3] as yeast prions. Yeast 11, 1671-1685.
37. +], a prion-like form of release factor eRF3. EMBO J. 18, 1182-1191.